Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-An effective EU regulatory approach

Vaccine

Volumn 30, Issue 27, 2012, Pages 4113-4122

  Wagner, Ralf ^a   Göpfert, Constanze ^a   Hammann, Joanna ^a   Neumann, Britta ^a   Wood, John ^b   Newman, Robert ^b   Wallis, Chantal ^b   Alex, Nina ^a   Pfleiderer, Michael ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Haemagglutination inhibition; Neutralisation; Pandemic influenza; Regulatory assessment; Serological assays; Vaccine immunogenicity

Indexed keywords

INFLUENZA VACCINE;

ANTIBODY BLOOD LEVEL; ARTICLE; CALCULATION; CALIBRATION; CONTROLLED STUDY; DRUG EFFICACY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; INFLUENZA A (H1N1); LABORATORY TEST; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; REPRODUCIBILITY; SEROLOGY; STANDARDIZATION; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; EUROPEAN UNION; FEMALE; HUMANS; IMMUNOASSAY; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; VACCINATION; YOUNG ADULT;

EID: 84861482095     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.077     Document Type: Article

References (31)

1. Zambon M.C. Laboratory diagnosis of influenza. Influenza 1997, 123-156. Blackwell publishing, Oxford (UK). K.G. Nicholson, R.G. Webster, A.J. Hay (Eds.).
2. World Health Organisation Global influenza programme [Internet] WHO manual on animal influenza diagnosis and surveillance 2002, Available from:, [accessed 31.01.2012]. http://www.who.int/csr/resources/publications/influenza/whocdscsrncs20025rev.pdf.
3. Committee for proprietary medicinal products of the European Medicines Agency (EMA) [Internet] Note for guidance on harmonization of requirements for influenza vaccines, CPMP/BWP/214/96 (12 March 1997) 1997, Available from:, [accessed 31.01.2012]. http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdf.
4. de Jong J.C., Palache A.M., Beyer W.E., Rimmelzwaan G.F., Boon A.C., Osterhaus A.D. Haemagglutination-inhibiting antibody to influenza virus. Laboratory correlates of immunity to influenza-a reassessment 2003, 115:63-73. Dev. Biol. Karger, Basel.
5. Hobson D., Curry R.L., Beare A.S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg 1972, 70:767-777.
6. Wood J.M., Newman R.W., Ploss K. The use of correlates of immunity in European Union licensing of influenza vaccines. Laboratory correlates of immunity to influenza-a reassessment 2003, 115:9-16. Dev. Biol. Karger, Basel.
7. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999, 37:937-943.
8. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997, 227:493-499.
9. Stephenson I., Wood J.M., Nicholson K.G., Zambon M.C. Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol 2003, 70:391-398.
10. Kayali G., Setterquist S.F., Capuano A.W., Myers K.P., Gill J.S., Gray G.C. Testing human sera for antibodies against avian influenza viruses: horse RBC hemagglutination inhibition vs. microneutralization assays. J Clin Virol 2008, 43:73-78.
11. Stephenson I., Wood J.M., Nicholson K.G., Charlett A., Zambon M.C. Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res 2004, 103:91-95.
12. Committee for medicinal products for human use of the European Medicines Agency (EMA) [Internet] Guideline on dossier structure and content for pandemic influenza vaccine marketing authorisation application, EMEA/CPMP/VEG/4717/03-Rev.1 (30 May 2008) 2008, Available from:, [accessed 31.01.2012]. http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500003993.pdf.
13. Stephenson I., Das R.G., Wood J.M., Katz J.M. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 2007, 25:4056-4063.
14. Stephenson I., Heath A., Major D., Newman R.W., Hoschler K., Junzi W., et al. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 2009, 15:1252-1259.
15. Wood J.M., Montomoli E., Newman R.W., Daas A., Buchheit K.H., Terao E. Collaborative study on influenza vaccine clinical trial serology. Part 2. reproducibility study. Pharmeur Bio Sci Notes 2011, 1:36-54.
16. Wood J.M., Newman R.W., Daas A., Terao E., Buchheit K.H. Collaborative study on influenza vaccine clinical trial serology. Part 1. CHMP compliance study. Pharmeur Bio Sci Notes 2011, 1:27-35.
17. World Health Organisation (WHO) Expert Committee on Biological Standardization [Internet] Report of a WHO collaborative study to assess the suitability of a candidate International Standard for antibody to pandemic H1N1 influenza virus, WHO/BS/10.2137 2010, Available from:, [accessed 31.01.2012]. http://whqlibdoc.who.int/hq/2010/WHO_BS_10.2137_eng.pdf.
18. Wood J.M., Major D., Heath A., Newman R.W., Höschler K., Stephenson I., et al. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 2012, 30:210-217.
19. National Institute for Biological Standards and Control (NIBSC) [Internet] Biological Reference Materials 2012, Available from:, [accessed 31.01.2012]. http://www.nibsc.ac.uk/products/biological_reference_materials.aspx.
20. World Health Organisation [Internet] Availability of a candidate reassortant vaccine virus for the novel influenza A (H1N1) vaccine development: X-179A (27 May 2009) 2009, Available from:, [accessed 31.01.2012]. http://www.who.int/csr/resources/publications/swineflu/2009_05_27_X179Aa.pdf.
21. Wood J.M., Gaines-Das R.E., Taylor J., Chakraverty P. Comparison of influenza serological techniques by international collaborative study. Vaccine 1994, 12:167-174.
22. Chen Z., Kadowaki S., Hagiwara Y., Yoshikawa T., Matsuo K., Kurata T., et al. Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase. Vaccine 2000, 18:3214-3222.
23. Couch R.B., Kasel J.A., Gerin J.L., Schulman J.L., Kilbourne E.D. Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis 1974, 129:411-420.
24. Gillim-Ross L., Subbarao K. Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses?. PLoS Med 2007, 4:e91.
25. Johansson B.E., Bucher D.J., Kilbourne E.D. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J Virol 1989, 63:1239-1246.
26. Johansson B.E., Matthews J.T., Kilbourne E.D. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine 1998, 16:1009-1015.
27. Powers D.C., Kilbourne E.D., Johansson B.E. Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults. Clin Diagn Lab Immunol 1996, 3:511-516.
28. Rimmelzwaan G.F., McElhaney J.E. Correlates of protection: novel generations of influenza vaccines. Vaccine 2008, 26(Suppl. 4):D41-D44.
29. Wright P.F., Neumann G., Kawaoka Y. Orthomyxoviruses. Fields Virology 2007, Lippincott Williams & Wilkins, Philadelphia, p. 1691-740. 5th ed. D.M. Knipe, P.M. Howley, M. Peter, D.E. Griffin (Eds.).
30. Wagner R., Matrosovich M., Klenk H.D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 2002, 12:159-166.
31. Russell S.M., McCahon D., Beare A.S. A single radial haemolysis technique for the measurement of influenza antibody. J Gen Virol 1975, 27:1-10.